Background: Triple-negative breast cancer (TNBC) is treated with highly aggressive non-
targeted chemotherapies. Safer and more effective therapeutic approaches than those …

The standard treatment for triple-negative breast cancer (TNBC) is chemotherapy, which is
highly toxic to patients; thereby, there is a need to identify safer and more effective …

Breast cancer is the most common cancer and the second leading cause of cancer death
and morbidity among women in the western world. Pomegranate juice (PJ) and three of its …

Purpose. Pomegranate fruit extracts (PFEs) possess polyphenolic and other compounds
with antiproliferative, pro-apoptotic and anti-inflammatory effects in prostate, lung, and other …

Several studies have demonstrated that polyphenolics from pomegranate (Punica granatum
L.) are potent inhibitors of cancer cell proliferation and induce apoptosis, cell cycle arrest …

Pomegranate (Punica granatum L.) is known to possess anticancer activities. The effects of
a standardized extract of pomegranate (PE) on a mouse mammary cancer cell line …

Cancer stem cells (CSCs) have become an important target population in cancer therapy
and prevention due to their ability to self-renew, initiate tumors, and resist therapy. We …

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that tends to
affect young women and has a high propensity to metastasize. No targeted treatments are …

Ovarian cancer is the third most common cancer in the female reproductive organs and
epithelial ovarian cancer has the highest lethality of all gynecological cancers. Pomegranate …

Punica granatum has a recorded history of pharmacological properties which can be
attributed to its rich reservoir of phytochemicals. Investigations in recent years have …